The United States is the world’s largest pharmaceutical market. Japan is the second largest, although the combined European Union is […]

Countries use various methods to control drug expenditures. Beyond simple negotiation, countries can also implement price controls or use WTO-authorized

Investing and Clinical Trials PharmaGossip has an illuminating excerpt from The End of Medicine describing a method to invest in

There’s been a lot of press floating around lately about the push to develop a framework for biogeneric (or biosimilar,

I’ve been invited to join the editorial board of the nascent Open Biotechnology Journal. The Open Biotechnology Journal is a

Scientific Advances The MaRS Blog has a captivating story of Canada’s recent major diabetes discovery. The first discovery, in 1920,

This edition of the Carnival of Biotechnology features a number of posts on distressing industry trends, some enlightening patent discussion,

Harvard’s Gary Pisano has recently published a book titled “Science Business: The Promise, the Reality, and the Future of Biotech“

Lots of interesting developments since the last edition: Pfizer’s high-profile drug failiure, a new law against violent extremists, good news